focus -WSS

focus

author：knowledge 2025-09-06 06:00:00 - browse：133

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Nonprofit, backed by Microsoft, to certify AI tools in health care

WSS

A preacher's new calling: Diversifying neuroscience research

3 questions for the future of Biden's cancer moonshot

FDA authorizes Novavax’s updated Covid

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

The high cost of giving birth even with insurance

American taxpayers paid $1.8 trillion in health care costs in 2022

Tori Bowie and the unacceptable rates of Black maternal death

Histogen: Failed biotech offers rare public look inside

After affirmative action ruling, medical educators look to 'holistic review'

FDA authorizes Novavax’s updated Covid

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A Q&A with the global head of Boehringer Ingelheim's innovation unit

State Dept. review finds Biden bears some blame for Afghanistan failures

Chan Zuckerberg Biohub Chicago to focus on inflammation

focus

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Colorectal cancer study finds potential in overlooked immune cell

Analysis of telehealth claims data suggest service duplication

FDA panel signals lack of confidence in Amgen cancer drug data

Stories you might have missed in 2023: health, science, medicine

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

knowledge

focus

hotspot

explore